STOCKHOLM, April 10, 2018 /PRNewswire/ -- Moberg Pharma┬┤s Annual Report for 2017 has been published and is available on www.mobergpharma.com

About this information

Moberg Pharma AB is obliged to make this information public pursuant to the EU Market Abuse Regulation (MAR). The information was submitted for publication, through the agency of the contact person set out above, at 08:30 a.m. (CET) on April 10th, 2018.

For more information, please contact:
Peter Wolpert
CEO
phone: +1-908-432-22-03 (US)
+46-70-735-71-35
e-mail: peter.wolpert@mobergpharma.se

Anna Ljung,
CFO
phone: +46-70-766-60-30
e-mail: anna.ljung@mobergpharma.se

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/moberg-pharma/r/moberg-pharma-annual-report-2017,c2490385

The following files are available for download:

http://mb.cision.com/Main/1662/2490385/818335.pdf

Moberg Pharma Annual Report 2017

Cision View original content:http://www.prnewswire.com/news-releases/moberg-pharma-annual-report-2017-300627023.html

SOURCE Moberg Pharma


Source: Moberg Pharma